Biohaven: Upgrading To Buy On Protein Degraders Pivotal Study Initiations

🇺🇸 Seeking Alpha (US) —
Biohaven: Upgrading To Buy On Protein Degraders Pivotal Study Initiations

AI Summary

Biohaven has upgraded its outlook to buy following the initiation of pivotal studies on protein degraders. This indicates growing confidence in the company's research and development pipeline.

Markets Health Biohaven protein degraders clinical studies healthcare stock upgrade pharmaceuticals

Read original source →